Home > News > JMAR Completes $3 Million Financing
December 29th, 2005
JMAR Completes $3 Million Financing
Abstract:
JMAR Technologies, Inc. (Nasdaq: JMAR) has completed a $3 million financing with twelve accredited investors. Midtown Partners & Co., LLC acted as sole placement agent in this transaction. "This financing, when added to JMAR's current cash position and untapped $3 million line of credit, enables JMAR to continue investment in our product development activities, including the BioSentry product line," commented Dennis E. Valentine, Chief Financial Officer of JMAR.
Source:
businesswire
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Water
Taking salt out of the water equation October 7th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||